Bevacizumab rechallenge in platinum-resistant ovarian cancer: Evidence from a propensity score–matched analysis. The role of combined T cell and NK cell activity in immune checkpoint inhibitor (ICI) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results